Tandem Diabetes Care Up 10%; To Work With Abbott
October 15 2019 - 10:45AM
Dow Jones News
By Michael Dabaie
Tandem Diabetes Care Inc. (TNDM) shares were up 10% to $62.14 in
Tuesday morning trading.
Abbott Laboratories (ABT) and Tandem said Tuesday they would
explore new integrated solutions for diabetes management.
The companies said they aim to integrate Abbott's FreeStyle
Libre glucose sensing technology with Tandem's insulin delivery
products.
Abbott shares were up 2% to $81.58.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
October 15, 2019 10:30 ET (14:30 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024
